Clinical and Economic Factors in the Selection of Drugs for Gastroesophageal Reflux Disease C. M. BateP. D. I. Richardson Leading Article 25 November 2012 Pages: 94 - 99
Health Economics in Primary Care in the UK T. WalleyR. T. Edwards Leading Article 25 November 2012 Pages: 100 - 106
Pharmacoeconomics of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Hilary A. WynneMark Campbell Review Article 25 November 2012 Pages: 107 - 123
Economic Aspects of General Anaesthesia S. P. RhodesS. Ridley Review Article 25 November 2012 Pages: 124 - 130
Cost-Effectiveness Study of a Lipid-Lowering Therapy in Hyperlipoproteinaemia Type IIb and Type IV (Frederickson) Rito BergemannArno BrandtWalter Siegrist Original Research Article 25 November 2012 Pages: 131 - 139
Misoprostol Lee B. BarradellRuth WhittingtonPaul Benfield Pharmacoeconomic Drug Evaluation 25 November 2012 Pages: 140 - 171
Impact of Triplicate Prescribing Programme on Psychotropic Prescribing Annet BedikianMark A. Gill Current Comment 25 November 2012 Pages: 172 - 173
COPD Education Reduces Consumption of Healthcare Services Birthe SendergaardHillerød RasmussenMette Rasmussen Current Comment 25 November 2012 Pages: 175 - 177